Preliminary results of a Phase III trial indicate that targeting agent Lymphoseek can identify head and neck cancer, reported Navidea Biopharmaceuticals, the maker of the agent. Lymphoseek is used to detect lymph nodes in patients with melanoma or breast cancer and to determine whether cancer has metastasized to a lymph node.

Full Story:

Related Summaries